Discover trends, market shifts, and competitive outlooks for the in-vitro lung model industry through 2025-2034 with The Business Research Company’s reliable data and in-depth research

What Are the Key Milestones in the In-Vitro Lung Model Market’s Growth Trajectory From 2025 To 2034?

Over the last few years, the market size of the in-vitro lung model has witnessed a rapid expansion. It is projected to increase from $0.44 billion in 2024 to $0.54 billion in 2025, at a compound annual growth rate (CAGR) of 21.3%. This significant growth during the historic period can be attributed to several factors, such as the rise in respiratory diseases, amplified attention on personalized medicine, increased interest in reusing drugs, focus on precision medicine methods, and a heightened awareness regarding environmental health risks.

In the coming years, the market size of the in-vitro lung model is expected to witness a skyrocketing growth, reaching $1.16 billion in 2029 with a compound annual growth rate (CAGR) of 21.0%. This projected growth during the forecast period is propelled by various factors such as the need for drug development, an increase in preclinical testing, heightened awareness about respiratory toxicology, a focus on regenerative medicine, escalating environmental worries, and a growing elderly population. The forecast period is also set to see dominant trends including a high demand for drug testing, breakthroughs in 3D printing technology and organ-on-chip technology, the fusion of AI and machine learning, the incorporation of sensors and tracking devices, widening applications outside pharmaceuticals, and the development of disease-specific models.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=15837&type=smp

Which Primay Drivers Are Accelerating Growth in the In-Vitro Lung Model Market?

The surge in clinical research is predicted to boost the expansion of the in vitro lung model market. Clinical studies, which evaluate new medical methodologies’ effectiveness in humans, are on the rise. This increase is fueled by the burgeoning demand for sophisticated medical treatments, escalating healthcare necessities, and the quest for groundbreaking solutions to intricate health concerns. In vitro lung models contribute to clinical trials by offering a regulated environment to examine the impact of substances on lung tissue, assisting in drug testing, toxicity evaluation, disease simulation, and comprehending disease processes. For instance, as per ClinicalTrials.gov, a US-run clinical trial registry, there were 477,230 clinical trials registered globally on ClinicalTrials.gov by the close of 2023. This signifies a rise when compared to 437,508 registered clinical trials in 2022. Consequently, the surge in clinical research is fueling the in vitro lung model market.

How Is the In-Vitro Lung Model Market Segmented?

The in-vitro lung model market covered in this report is segmented –

1) By Type: Two-Dimensional (2D) Model, Three-Dimensional (3D) Model

2) By Application: Drug Discovery And Toxicology Studies, Physiological Research, Three-Dimensional (3D) Model Development, Other Applications

3) By End-User: Academic Research Institutes, Pharmaceutical And Biotechnology Companies, Other End-Users

Subsegments:

1) By Two-Dimensional (2D) Model: Monolayer Cell Cultures, Co-cultures

2) By Three-Dimensional (3D) Model: Spheroids, Organoids, Lung-On-A-chip Models

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=15837&type=smp

Which Regions Are Key Players in the Growth of the In-Vitro Lung Model Market?

North America was the largest region in the in-vitro lung model market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the in-vitro lung model market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

What Key Trends Are Shaping the Future of the In-Vitro Lung Model Market?

Key players in the invitro lung model market are now focusing on creating 3D respiratory tissue models to increase the physiological relevance and intricacy of their models. This is done by growing particular respiratory cells in a unique environment that enables them to form into a structure mimicking the functionality and morphology of the respiratory system, hence presenting a platform that is more relevant physiologically for research and drug testing purposes. For example, MatTek Corporation, a biotechnology company from the US, launched EpiNasal in April 2023, which is a novel 3D respiratory tissue model constructed from primary human nasal epithelial cells. This model successfully simulates the three-dimensional structure and operation of the nasal epithelium, inclusive of functional tight junctions, mucus-producing goblet cells, and beating cilia. The introduction of EpiNasal has expanded MatTek’s array of 3D respiratory tissue models, offering a comprehensive system to analyze the impact of pharmaceuticals, chemicals, pathogens, and consumer products on the human respiratory system.

View the full report here:

https://www.thebusinessresearchcompany.com/report/in-vitro-lung-model-global-market-report

How Is the In-Vitro Lung Model Market Defined and What Are Its Core Parameters?

An In-Vitro lung model is a scientific construct designed to imitate the cellular, structural, and functional properties of the human lung in a controlled laboratory environment. These models enable researchers to investigate illness development, discover biomarkers, and assess treatment efficacy. They are useful tools for better understanding lung biology, developing therapies, and improving health outcomes.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=15837

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

[KClientError] [REQ_ERR: OPERATION_TIMEDOUT] [KTrafficClient] Something is wrong.